Frühe Nutzenbewertung: Aktuelle Stellungnahmen der DGVS

View at publisher Summarise with VIRAT
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Stellungnahme zur Nutzenbewertung Bulevirtid (Neubewertung Orphan > 30 Mio.: Hepatitis-Delta-Virus (HDV)-Infektion, HDV-RNA-positiv, ≥ 3 Jahre, ≥ 10 kg KG) Publication History Article published online: 20 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Fields of Study & Subjects

Hepatitis B Virus Studies Health Systems Economic Evaluations Quality of Life Hepatitis C virus research

Publication details

Journal / source
Zeitschrift für Gastroenterologie
Volume
64
Issue
03
Pages
302–302
Publication date
1 March 2026
Language
DE